Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mass. vitamin settlement

This article was originally published in The Tan Sheet

Executive Summary

Fairness hearing slated for Aug. 28 in Cambridge state court on $19.6 mil. class action settlement of consumers' vitamin price-fixing claims against seven ingredient suppliers. Under the agreement tentatively approved April 22, settling defendants BASF, Daiichi Pharmaceutical, Eisai, Aventis Animal Nutrition, Hoffman-La Roche, Roche Vitamins and Takeda Chemical Industries deny liability. Settlement proceeds would be allocated to charitable groups providing food and nutrition programs in the state. Massachusetts consumers' indirect claims were not part of multi-state settlement involving the same defendants in October 2000 (1"The Tan Sheet" Oct. 16, 2000, p. 5)...

You may also be interested in...



Vitamin Price-Fixing $335 Mil. Settlement Reached For Indirect Purchasers

Twenty-four states and U.S. jurisdictions will use $145.6 mil. in proceeds from vitamin price-fixing settlements to fund health, education and scientific programs such as prenatal care and nutrition research.

Investors Go Beserk For Viking, Putting It Top Of Q1 Winners

The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094003

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel